Bull Case

Revenue growth re-accelerates as demand normalizes and pricing improves, lifting sales above peers with similar cyclical exposure.

Operating leverage turns positive from a -17.6% TTM margin base, allowing fixed-cost absorption to expand EBITDA faster than peer averages.

Cash generation improves as working-capital release and better margins reduce the current negative free-cash-flow profile versus more leveraged peers.

Balance-sheet pressure eases if EBITDA recovery improves net debt metrics, lowering refinancing risk relative to peers with weaker coverage.

Base Case

Revenue stabilizes with modest growth, but the absence of visible multi-year CAGR support keeps MRT near peer median rather than leading them.

Margins improve only gradually from the current -17.6% operating margin, leaving profitability below stronger peers that already convert scale into earnings.

Negative free cash flow narrows but remains inconsistent, so valuation stays anchored to sales rather than earnings like higher-quality peers.

Leverage remains manageable only if EBITDA recovers slowly, keeping interest coverage weaker than peers with positive and more durable cash generation.

Bear Case

Demand softens or pricing weakens, pushing revenue below peers and preventing any operating deleveraging from the current loss-making base.

Persistent negative margins widen losses, causing EBITDA and free cash flow to remain negative while peers preserve at least partial profitability.

High leverage becomes more constraining as weak EBITDA keeps net debt and interest coverage unfavorable versus better-capitalized peers.

Liquidity pressure forces dilution or asset sales if cash burn persists, structurally impairing forward returns relative to peers.

Overall Score

MRT’s forward path is most likely a gradual recovery from a weak profitability and leverage base, with upside dependent on margin normalization and cash generation.